MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 125 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $34,000 | -89.1% | 27,500 | -72.9% | 0.00% | -100.0% |
| Q1 2017 | $312,000 | +47.9% | 101,400 | +95.4% | 0.01% | +66.7% |
| Q4 2016 | $211,000 | +229.7% | 51,900 | +408.8% | 0.00% | +200.0% |
| Q3 2016 | $64,000 | +1500.0% | 10,200 | +18114.3% | 0.00% | – |
| Q3 2015 | $4,000 | -85.7% | 56 | -90.7% | 0.00% | -100.0% |
| Q1 2015 | $28,000 | -65.9% | 600 | -14.3% | 0.00% | -50.0% |
| Q4 2014 | $82,000 | +67.3% | 700 | -59.4% | 0.00% | +100.0% |
| Q3 2014 | $49,000 | -76.7% | 1,724 | -46.9% | 0.00% | -80.0% |
| Q2 2014 | $210,000 | +36.4% | 3,248 | -35.7% | 0.01% | +66.7% |
| Q1 2014 | $154,000 | +51.0% | 5,053 | +823.8% | 0.00% | +50.0% |
| Q4 2013 | $102,000 | – | 547 | +2504.8% | 0.00% | – |
| Q3 2013 | $0 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |